BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11323161)

  • 1. Up-regulation of transporters of the MRP family by drugs and toxins.
    Schrenk D; Baus PR; Ermel N; Klein C; Vorderstemann B; Kauffmann HM
    Toxicol Lett; 2001 Mar; 120(1-3):51-7. PubMed ID: 11323161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
    Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
    Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes.
    Kauffmann HM; Keppler D; Kartenbeck J; Schrenk D
    Hepatology; 1997 Oct; 26(4):980-5. PubMed ID: 9328323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multidrug resistance protein family.
    Borst P; Evers R; Kool M; Wijnholds J
    Biochim Biophys Acta; 1999 Dec; 1461(2):347-57. PubMed ID: 10581366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.
    König J; Nies AT; Cui Y; Leier I; Keppler D
    Biochim Biophys Acta; 1999 Dec; 1461(2):377-94. PubMed ID: 10581368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
    Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
    Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated protein subfamily transporters and drug resistance.
    Kuwano M; Toh S; Uchiumi T; Takano H; Kohno K; Wada M
    Anticancer Drug Des; 1999 Apr; 14(2):123-31. PubMed ID: 10405639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1.
    Conrad S; Viertelhaus A; Orzechowski A; Hoogstraate J; Gjellan K; Schrenk D; Kauffmann HM
    Toxicology; 2001 Jan; 156(2-3):81-91. PubMed ID: 11164610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP binding cassette transporter gene expression in rat liver progenitor cells.
    Ros JE; Roskams TA; Geuken M; Havinga R; Splinter PL; Petersen BE; LaRusso NF; van der Kolk DM; Kuipers F; Faber KN; Müller M; Jansen PL
    Gut; 2003 Jul; 52(7):1060-7. PubMed ID: 12801967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells.
    Payen L; Courtois A; Langouët S; Guillouzo A; Fardel O
    Toxicology; 2001 Jan; 156(2-3):109-17. PubMed ID: 11164613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters.
    Zhao Y; Feng L; Liu L; Zhao R
    Life Sci; 2019 Aug; 231():116557. PubMed ID: 31194994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites.
    Kauffmann HM; Vorderstemann B; Schrenk D
    Toxicology; 2001 Oct; 167(1):25-35. PubMed ID: 11557127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.
    Stöckel B; König J; Nies AT; Cui Y; Brom M; Keppler D
    Eur J Biochem; 2000 Mar; 267(5):1347-58. PubMed ID: 10691972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D
    Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
    Suzuki H
    Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic secretion of conjugated drugs and endogenous substances.
    Keppler D; König J
    Semin Liver Dis; 2000; 20(3):265-72. PubMed ID: 11076395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of amphipathic anions by human multidrug resistance protein 3.
    Zeng H; Liu G; Rea PA; Kruh GD
    Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport.
    Uchiumi T; Hinoshita E; Haga S; Nakamura T; Tanaka T; Toh S; Furukawa M; Kawabe T; Wada M; Kagotani K; Okumura K; Kohno K; Akiyama S; Kuwano M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):103-10. PubMed ID: 9813153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.